Zobrazeno 1 - 10
of 85
pro vyhledávání: '"xenical"'
Autor:
Semira Abdi Beshir, Asim Ahmed Elnour, Aadith Soorya, Affana Parveen Mohamed, Sheron Sir Loon Goh, Nadia Hussain, Amal H.I. Al Haddad, Faizah Hussain, Israa Yousif Khidir, Zainab Abdelnassir
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 10, Pp 101757- (2023)
Background: Recently, many drugs have been approved for halting overweight and obesity—few types of research shifted to using Anti-obesity medications (AOM) solely for well-being and shape-keeping. Objective: This narrative review's objective was t
Externí odkaz:
https://doaj.org/article/522958a126bc4743b79a7176206fbf54
Autor:
Cordes, Eugene H., author
Publikováno v:
Hallelujah Moments : Tales of Drug Discovery, 2020, ill.
Externí odkaz:
https://doi.org/10.1093/oso/9780190080457.003.0011
Publikováno v:
Ожирение и метаболизм, Vol 10, Iss 3, Pp 19-26 (2013)
This review article discusses the similarities and differences in the research, production and use in clinical practice, original and generic drugs. Reproduced drugs (generics) present on the Russian pharmaceutical market that have the bioequivalence
Externí odkaz:
https://doaj.org/article/a21429151c7d4a499739db0c825017e8
Publikováno v:
Ожирение и метаболизм, Vol 7, Iss 4, Pp 29-34 (2010)
Obesity plays a key role in reproductive disorders. Xenical administration results in recovery of menstrual function in 78.9% and ovulation in 26.3% of patients with obesity. Hormone therapy in patients with obesity should be accompanied with Xenical
Externí odkaz:
https://doaj.org/article/5c442b7f0753433690868380a3b5f0d9
Publikováno v:
Ожирение и метаболизм, Vol 7, Iss 2, Pp 22-27 (2010)
Резюме. В статье обсуждаются проблемы ожирения и его вклад в сердечно-сосудистый и метаболические риски пациентов. Отмечено увеличение
Externí odkaz:
https://doaj.org/article/e2ecc44056a74121b1d644d8f503c2ab
Publikováno v:
Ожирение и метаболизм, Vol 7, Iss 1, Pp 34-39 (2010)
This article shows a significant efficacy and safety data of original drug Xenical in complex treatment of overweight and obesity patients. It is emphasized that this data describe properties of original Xenical, but not generics. The generic drug Or
Externí odkaz:
https://doaj.org/article/3d473a0009f54b11b2eb669fefad2548
Publikováno v:
Ожирение и метаболизм, Vol 6, Iss 4, Pp 38-41 (2009)
There is abdominal obesity in men that is accompanied with high risk of concomitant disease. The different authors data about close relation between obesity and metabolic syndrome with hypogonadism in men are performed in this article. Reduction of b
Externí odkaz:
https://doaj.org/article/0ded4926c401486ebd90d429921d79b9
Publikováno v:
Терапевтический архив, Vol 79, Iss 1, Pp 49-53 (2004)
Aim. To study effects ofxenical combined with moderately hypocaloric diet on fat tissue mass, carbohydrate and lipid metabolism in patients with metabolic syndrome. Material and methods. The study included 60 patients with body mass index (BMI) over
Externí odkaz:
https://doaj.org/article/f9b729d55bb6434998480f8ee98d1803
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nicolás Ried, Ricardo Camargo
Publikováno v:
Alpha (Osorno) n.50 2020
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Resumen: En Towards a genealogy of pharmaceutical practice (Camargo y Ried, 2016), sostuvimos que la práctica farmacológica daba lugar a un nuevo tipo de biopoder (“biopoder molecular”), con tecnologías y racionalidades propias, que lo disting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f2e4ccff05423dfc7eb68261d98f18
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-22012020000100009
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-22012020000100009
